International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, International Maternal Pediatric Adolescent AIDS Clinical Trials Group sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
International Maternal Pediatric Adolescent AIDS Clinical Trials Group: 17 sponsored US clinical trials, 2 recruiting.
International Maternal Pediatric Adolescent AIDS Clinical Trials Group sponsors 17 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 12 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 2 trials.
Top-decile sponsor footprint
International Maternal Pediatric Adolescent AIDS Clinical Trials Group ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
NCT07293559
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
NCT07207876
Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
NCT07637942
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
NCT05154513
IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive Impairment
NCT03416790
IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV
NCT02939131
IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
NCT02140944
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
NCT01338025
IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
NCT01232361
IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody
NCT01206556
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
NCT00955968
Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
NCT01484522
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
NCT00663234
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
NCT01061164
Psychiatric Problems in Children and Adolescents Infected With HIV at Birth
NCT00100542
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
NCT00028145
IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
NCT00977756
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
Where International Maternal Pediatric Adolescent AIDS Clinical Trials Group enrollment is open (later-stage tilt)
2 recruiting of 17 indexed (12% open); 12 completed (71%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: HIV Infections (2 trials), 6 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
International Maternal Pediatric Adolescent AIDS Clinical Trials Group: open-pipeline peers nationwide
Peers matched on 17 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
International Maternal Pediatric Adolescent AIDS Clinical Trials Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Cochlear · 12% recruiting · 34 trials
- Erchonia Corporation · 12% recruiting · 34 trials
- Hutchmed · 12% recruiting · 17 trials
- PrECOG · 12% recruiting · 17 trials
Related
What to do with this International Maternal Pediatric Adolescent AIDS Clinical Trials Group page
17 registered trials is a research-attention snapshot, not an endorsement of International Maternal Pediatric Adolescent AIDS Clinical Trials Group or any single study.
- 2 of International Maternal Pediatric Adolescent AIDS Clinical Trials Group's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition International Maternal Pediatric Adolescent AIDS Clinical Trials Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
International Maternal Pediatric Adolescent AIDS Clinical Trials Group pipeline card: 17 registered trials from official public datasets.Report a data error.